demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
bromhexine Li T

2 studies excluded by filtering options 0

5536 Ansarin, 2020 113high risk of bias
6767 Tolouian, 2021 103high risk of bias